Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA), Initial Review, 19996 [2011-8508]

Download as PDF 19996 Federal Register / Vol. 76, No. 69 / Monday, April 11, 2011 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Food and Drug Administration Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA), Initial Review Cooperative Agreement With the University of Mississippi’s National Center for Natural Products Research (U01) To Develop and Disseminate Botanical Natural Product Research With an Emphasis on Public Safety [Docket No. FDA–2011–N–0012] The meeting announced below concerns ‘‘Longitudinal Study of a Population-based Cohort of People with Lupus,’’ FOA DP11–004, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11 a.m.–5 p.m., May 04, 2011 (Closed). Place: Teleconference Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Longitudinal Study of a Population-based Cohort of People with Lupus,’’ FOA DP11–004, initial review. Contact Person for More Information: Brenda Colley Gilbert, Ph.D., M.P.H., Director, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 1600 Clifton Road, NE., Mailstop K92, Atlanta, Georgia 30333, Telephone: (770) 488–6295. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 4, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–8508 Filed 4–8–11; 8:45 am] srobinson on DSKHWCL6B1PROD with NOTICES BILLING CODE 4163–18–P VerDate Mar<15>2010 18:59 Apr 08, 2011 Jkt 223001 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing the availability of grant funds for the support of a cooperative agreement with the University of Mississippi’s National Center for Natural Products Research (UM–NCNPR). The goal of the cooperative agreement is to promote the efficient development and dissemination of natural products research and science and the programs developed under the agreement will complement the diverse activities of both the public and private sectors. DATES: Important dates are as follows: 1. The application due date is May 1, 2011. 2. The anticipated start date is June 1, 2011. 3. The opening date is April 11, 2011. 4. The expiration date is May 2, 2011. For Further Information and Additional Requirements Contact: Scientific/Programmatic Contacts: Jeanne I. Rader, Center for Food Safety and Applied Nutrition (HFS–715), 5100 Paint Branch Pkwy., College Park, MD 20740, 301–436–1786, FAX: 301–436–2622, e-mail: Jeanne.Rader@fda.hhs.gov; or Steven L. Robbs, Center for Food Safety and Applied Nutrition (HFS–006), 5100 Paint Branch Pkwy., College Park, MD 20740, 301–436–2146, FAX: 301–436–2618, e-mail: Steven.Robbs@fda.hhs.gov; or LaQuia S. Geathers, Center for Food Safety and Applied Nutrition (HFS– 680), 5100 Paint Branch Pkwy., College Park, MD 20740, 301–436– 2821, FAX: 301–436–2629, e-mail: LaQuia.Geathers@fda.hhs.gov. Grants Management Contact: Vieda Hubbard, Office of Acquisitions and Grants Services (HFA–500), 5630 Fishers Lane, Rm. 2141, Rockville, MD 20857, 301–827–7177, FAX: 301– 827–7101, e-mail: Vieda.Hubbard@fda.hhs.gov. For more information on this funding opportunity announcement (FOA) and SUMMARY: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 to obtain detailed requirements, please refer to the full FOA located at https:// grants2.nih.gov/grants/guide and https:// www.fda.gov/Food/NewsEvents/ default.htm. SUPPLEMENTARY INFORMATION: I. Funding Opportunity Description RFA–FD–11–004 Catalog of Federal Domestic Assistance Number(s): 93.103 https:// www.cfda.gov. A. Background The primary focus of the UM– NCNPR/FDA cooperative agreement is to develop and disseminate botanical natural product research with an emphasis on public safety according to the needs of FDA. The cooperative research, education, and outreach programs developed by UM–NCNPR will address scientific issues related to the safety of botanical dietary supplements (BDS) and botanical ingredients and will complement the diverse activities of both the public and private sectors. B. Research Objectives This cooperative agreement will define the research projects, workshops, conferences, partnerships with academia, industry, non-governmental organizations, and international organizations and other activities on which the FDA and UM–NCNPR will collaborate. Specifically, this cooperative agreement will provide continued support so that UM–NCNPR can: • Assist in the identification and development of a list of BDS and botanical ingredients, based on safety concerns, trends, and knowledge of botanicals being marketed in the United States, to prioritize for further research. • Acquire, validate, and characterize authenticated reference materials, including raw and processed plant materials and purified natural products of relevance to FDA, for evaluation of their safety. • Exchange technical and scientific information, analytical methods, and reference material with FDA scientists and other stakeholders. • Collaborate with FDA scientists in research areas of mutual interest. • Coordinate scientific workshops and conferences on BDS-related topics of public health relevance to address high priority science and research needs. C. Eligibility Information NCNPR has the unique capability to bring together diverse scientific E:\FR\FM\11APN1.SGM 11APN1

Agencies

[Federal Register Volume 76, Number 69 (Monday, April 11, 2011)]
[Notices]
[Page 19996]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8508]



[[Page 19996]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Funding Opportunity Announcement (FOA), Initial 
Review

    The meeting announced below concerns ``Longitudinal Study of a 
Population-based Cohort of People with Lupus,'' FOA DP11-004, initial 
review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date:
11 a.m.-5 p.m., May 04, 2011 (Closed).
    Place: Teleconference
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Longitudinal Study of a Population-based Cohort of 
People with Lupus,'' FOA DP11-004, initial review.
    Contact Person for More Information: Brenda Colley Gilbert, 
Ph.D., M.P.H., Director, Extramural Research Program Office, 
National Center for Chronic Disease Prevention and Health Promotion, 
CDC, 1600 Clifton Road, NE., Mailstop K92, Atlanta, Georgia 30333, 
Telephone: (770) 488-6295.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: April 4, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-8508 Filed 4-8-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.